Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Zosano Pharma (ZSAN)

Zosano Pharma (ZSAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Zosano Pharma Reports First Quarter 2022 Financial Results Globe Newswire - Fri May 13, 2022

FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Provides Corporate Update Globe Newswire - Fri Apr 29, 2022

FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Reverse Stock Split Effective Today Globe Newswire - Mon Apr 11, 2022

ZSAN common stock expected to begin trading on a split-adjusted basis on April 12, 2022...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results Globe Newswire - Thu Mar 17, 2022

FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants Globe Newswire - Tue Feb 8, 2022

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants Globe Newswire - Tue Feb 8, 2022

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)
CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose Globe Newswire - Wed Jan 5, 2022

—Data published in the Journal of Vaccines and Immunology—...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose Globe Newswire - Wed Jan 5, 2022

—Data published in the Journal of Vaccines and Immunology—...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. Yang Globe Newswire - Mon Dec 13, 2021

FREMONT, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Mon Nov 29, 2021

FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)

Barchart Exclusives

3 Top Dividend Stocks to Buy This September Barchart - Wed Sep 18, 6:30PM CDT
After today's jumbo rate cut from the Fed, here are three dividend stocks to bolster your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot